How Sglt-2 Inhibitors Improve Glycemic Control in Type 2 Diabetes

in #mrmed • 3 years ago

Chronic metabolic disease known as type 2 diabetes mellitus (T2DM) is characterised by elevated blood sugar levels and insulin resistance. The development of sodium-glucose cotransporter-2 (SGLT-2) inhibitors is one important development in the treatment of T2DM that has occurred throughout the years. Dapagliflozin-containing Forxiga 10 was created to treat diabetes and has completely changed how glycemic management is approached.

#mrmedpharmacy #diabetes #type2diabetes #sglt2inhibitors #forxiga10mg
3 years ago in #mrmed by
$0.00
    Reply 0

    Coin Marketplace

    STEEM 0.05
    TRX 0.29
    JST 0.045
    BTC 66375.55
    ETH 1915.93
    USDT 1.00
    SBD 0.38